These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7680057

  • 1. Further analyses of epitopes for human monoclonal anti-basement membrane zone antibodies produced by stable human hybridoma cell lines constructed with Epstein-Barr virus transformants.
    Hashimoto T, Amagai M, Ebihara T, Gamou S, Shimizu N, Tsubata T, Hasegawa A, Miki K, Nishikawa T.
    J Invest Dermatol; 1993 Mar; 100(3):310-5. PubMed ID: 7680057
    [Abstract] [Full Text] [Related]

  • 2. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T, Hashimoto T, Hibi T, Nishikawa T.
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [Abstract] [Full Text] [Related]

  • 3. Human monoclonal anti-basement membrane zone antibodies derived from virally transformed lymphocytes of a patient with bullous pemphigoid recognize epitopes associated with hemidesmosomes.
    Shimizu H, Hashimoto T, Nishikawa T, Eady RA.
    Br J Dermatol; 1991 Mar; 124(3):217-20. PubMed ID: 1708270
    [Abstract] [Full Text] [Related]

  • 4. Partial cDNA cloning of the 230-kD mouse bullous pemphigoid antigen by use of a human monoclonal anti-basement membrane zone antibody.
    Amagai M, Hashimoto T, Tajima S, Inokuchi Y, Shimizu N, Saito M, Miki K, Nishikawa T.
    J Invest Dermatol; 1990 Sep; 95(3):252-9. PubMed ID: 2200830
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies to various morphologic components of human skin.
    Aiba S, Masuko T, Hosokawa M, Hashimoto Y.
    J Invest Dermatol; 1983 Dec; 81(6):498-502. PubMed ID: 6196419
    [Abstract] [Full Text] [Related]

  • 6. Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein.
    Gaucherand M, Nicolas JF, Paranhos Baccala G, Rouault JP, Réano A, Magaud JP, Thivolet J, Jolivet M, Schmitt D.
    Br J Dermatol; 1995 Feb; 132(2):190-6. PubMed ID: 7534103
    [Abstract] [Full Text] [Related]

  • 7. Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core antigen.
    Siemoneit K, da Silva Cardoso M, Wölpl A, Koerner K, Subanek B.
    Hybridoma; 1994 Feb; 13(1):9-13. PubMed ID: 7515376
    [Abstract] [Full Text] [Related]

  • 8. Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults.
    Kitamura K, Yamada K, Kuzushima K, Morishima T, Morishima Y, Yamamoto N, Nishiyama Y, Ohya K, Yamaguchi H.
    J Med Virol; 1990 Sep; 32(1):60-6. PubMed ID: 2173739
    [Abstract] [Full Text] [Related]

  • 9. Human monoclonal antibodies against Plasmodium falciparum: production, stabilization and characterization.
    Kamber M, Blackman M, Lin PS, Brown J, Whittle H, Schmidt-Ullrich R.
    Parasite Immunol; 1992 Jul; 14(4):451-6. PubMed ID: 1279503
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
    Siaw MF, Nemerow GR, Cooper NR.
    J Immunol; 1986 Jun 01; 136(11):4146-51. PubMed ID: 3009616
    [Abstract] [Full Text] [Related]

  • 11. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A.
    J Invest Dermatol; 1997 Jun 01; 108(6):854-8. PubMed ID: 9182810
    [Abstract] [Full Text] [Related]

  • 12. Human monoclonal antibodies.
    Cole SP, Campling BG, Atlaw T, Kozbor D, Roder JC.
    Mol Cell Biochem; 1984 Jun 01; 62(2):109-20. PubMed ID: 6087121
    [Abstract] [Full Text] [Related]

  • 13. Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.
    Tanaka Y, Yoshida A, Tozawa H, Shida H, Nyunoya H, Shimotohno K.
    Int J Cancer; 1991 Jun 19; 48(4):623-30. PubMed ID: 1710610
    [Abstract] [Full Text] [Related]

  • 14. New monoclonal antibodies against colon cancer-associated antigens.
    Drewinko B, Yang LY, Chan J, Trujillo JM.
    Cancer Res; 1986 Oct 19; 46(10):5137-43. PubMed ID: 2428473
    [Abstract] [Full Text] [Related]

  • 15. Human--human hybridomas secreting lipid A reactive monoclonal antibodies.
    Ramachandra RN, Berczi I, Sehon AH.
    Immunol Lett; 1988 Jun 19; 18(2):93-7. PubMed ID: 2456987
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ, Petti L, Rowe M.
    J Gen Virol; 1994 Apr 19; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [Abstract] [Full Text] [Related]

  • 18. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A, Kawase T, Ida A, Maeda Y, Ohba H, Ikeda Y, Sato H, Takahashi M, Chiba J.
    Hum Antibodies; 2006 Apr 19; 15(4):139-54. PubMed ID: 17522436
    [Abstract] [Full Text] [Related]

  • 19. Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV).
    Bron D, Delforge A, Lagneaux L, De Martynoff G, Bosmans E, Van der Auwera P, Snoeck R, Burny A, Stryckmans P.
    J Immunol Methods; 1990 Jul 03; 130(2):209-16. PubMed ID: 2165098
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.